Krayenbühl Niklaus, Erdem Eren, Oinas Minna, Krisht Ali F
Department of Neurosurgery, University Hospital Zürich, Frauenklinikstr. 10, 8091 Zürich, Switzerland.
Stroke. 2009 Jan;40(1):129-33. doi: 10.1161/STROKEAHA.108.524777. Epub 2008 Oct 30.
Silent ischemic events are known to occur during diagnostic and interventional endovascular procedures between 10% and 69% of the time. The occurrence of silent and symptomatic ischemic events in the surgically treated population is not known, although atherosclerotic changes of intracranial vessels or within the aneurysms wall or neck area are seen often during surgery.
Patients with unruptured and ruptured intracranial aneurysms treated by microsurgical clipping were prospectively evaluated with MRI using diffusion-weighted imaging sequences before and within 24 hours after surgery. Patients were evaluated clinically before and after surgery. During surgery, the overall and maximal time of temporary occlusion as well as the total number of temporary and finally applied clips was noted. Diffusion-weighted images were analyzed with determination and characterization of diffusion-weighted imaging abnormalities.
Thirty-six patients with 51 aneurysms were included. One symptomatic and 5 silent ischemic lesions were found in 5 patients. This represents a risk of silent ischemia of 9.8% per treated aneurysm and a risk of symptomatic stroke of 2%. The most significant risk factor in increasing order was: age (P<0.05), presence of thrombus (P<0.05), number of final clips applied (P<0.05), number of temporary clips used (P<0.01), total time of temporary clip occlusion (P<0.001), and maximal time of temporary occlusion (P<0.001).
The risk of silent and symptomatic ischemic events during microsurgical clipping of intracranial aneurysms seems to be low. Microsurgical clipping is safe and should continue to be strongly considered as a treatment option.
已知在诊断性和介入性血管内手术过程中,无症状缺血事件的发生率在10%至69%之间。尽管在手术过程中经常可见颅内血管或动脉瘤壁或颈部区域的动脉粥样硬化改变,但手术治疗人群中无症状和有症状缺血事件的发生率尚不清楚。
对通过显微手术夹闭治疗的未破裂和破裂颅内动脉瘤患者,在手术前和术后24小时内使用扩散加权成像序列进行MRI前瞻性评估。在手术前后对患者进行临床评估。在手术过程中,记录临时阻断的总时间和最长时间以及临时和最终应用夹子的总数。对扩散加权图像进行分析,确定并描述扩散加权成像异常情况。
纳入36例患者的51个动脉瘤。在5例患者中发现1例有症状和5例无症状缺血性病变。这意味着每个治疗的动脉瘤无症状缺血风险为9.8%,有症状性卒中风险为2%。按递增顺序排列,最显著的风险因素为:年龄(P<0.05)、血栓形成(P<0.05)、最终应用夹子的数量(P<0.05)、使用临时夹子的数量(P<0.01)、临时夹子阻断的总时间(P<0.001)和临时阻断的最长时间(P<0.001)。
颅内动脉瘤显微手术夹闭过程中无症状和有症状缺血事件的风险似乎较低。显微手术夹闭是安全的,应继续被强烈视为一种治疗选择。